Work

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes

Year: 2013

Type: article

Source: Leukemia

DOI: 10.1038/leu.2013.160

Authors: D M Murphy, R Bejar, K Stevenson, D Neuberg, Y Shi, C Cubrich, K Richardson, P Eastlake, G Garcia-Manero, H Kantarjian, B L Ebert, G Mike Makrigiorgos

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, University of California San Diego, Moores Cancer Center, Transgenomic (United States), The University of Texas MD Anderson Cancer Center, Brigham and Women's Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Leukemia and Lymphoma Society, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G111615301, G1853313066, Functional Genomic Dissection of Refractory Anemia, High-throughput technology that enables sequencing depth for colorectal CA, G4519919871, New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS), G5740456546, Characterization of Genetic Abnormalities in MDS and Their Clinical Impact, G6300475257, GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATION, Cancer Center Support Grant

OpenAlex ID: W2021327643

FWCI: 4.884

Cites: 15

Cited by: 59

Related to: 10